Literature DB >> 4877872

Bronchospasm after inhalation of pancreatic dornase.

P Raskin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4877872     DOI： 10.1164/arrd.1968.98.4.697

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  8 in total

1.  Using Pulmozyme DNase treatment in lentiviral vector production.

Authors:  Aaron Shaw; Daniela Bischof; Aparna Jasti; Aaron Ernstberger; Troy Hawkins; Kenneth Cornetta
Journal:  Hum Gene Ther Methods       Date:  2012-02       Impact factor: 2.396

2.  Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.

Authors:  C M Costello; C M O'Connor; G A Finlay; P Shiels; M X FitzGerald; J P Hayes
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 3.  Human recombinant DNase in cystic fibrosis.

Authors:  A H Thomson
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

4.  Long-term effects of aerosolised rhDNase on pulmonary disease progression in patients with cystic fibrosis.

Authors:  C E Milla
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

5.  Targeting of dornase alpha therapy in adult cystic fibrosis.

Authors:  M J Ledson; Z Wahbi; R P Convery; C Cowperthwaite; D P Heaf; M J Walshaw
Journal:  J R Soc Med       Date:  1998-07       Impact factor: 5.344

Review 6.  Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

7.  Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.

Authors:  P L Shah; S F Scott; H J Fuchs; D M Geddes; M E Hodson
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

8.  Infections in cystic fibrosis.

Authors:  Kathy A Marks-Austin; Stanley B Fiel; Preston W Campbell; Terrence L Stull
Journal:  Semin Pediatr Infect Dis       Date:  2006-05-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.